Christopher J Ong

Title: Christopher J Ong: Innovator in Cancer Therapeutics

Introduction

Christopher J Ong is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of cancer therapeutics, holding a total of seven patents. His work focuses on innovative methods and compositions for treating various types of cancer, showcasing his dedication to advancing medical science.

Latest Patents

One of Ong's latest patents is titled "B1SP fusion protein therapeutics, methods, and uses." This patent provides methods, uses, and pharmaceutical compositions for the treatment of cancer using a B1SP fusion protein. The protein is designed to be administered in a biologically effective amount sufficient to induce cell death in prostate cancer cells or to inhibit their proliferation. The cancers targeted by this invention include prostate cancer, breast cancer, ovarian cancer, bladder cancer, kidney cancer, glioblastoma, and endometrial cancer. Notably, the prostate cancer may be androgen receptor (AR) positive, and the B1SP fusion protein may incorporate a sema domain, a structural stabilization domain, and a half-life extending moiety.

Career Highlights

Christopher J Ong has worked with esteemed institutions such as the University of British Columbia and the British Columbia Cancer Agency Branch. His career reflects a commitment to research and innovation in the medical field, particularly in cancer treatment.

Collaborations

Ong has collaborated with notable professionals in his field, including Martin E Gleave and James William Peacock. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Christopher J Ong is a distinguished inventor whose work in cancer therapeutics has the potential to significantly impact patient care. His innovative approaches and collaborations highlight his commitment to improving treatment options for various cancers.